Chie Oshita

发表

Identification of a New Series of STAT3 Inhibitors by Virtual Screening.

Kenji Matsuno, Masami Otsuka, Hidee Ishii, 2010, ACS medicinal chemistry letters.

Analysis of HLA‐A24‐restricted peptides of carcinoembryonic antigen using a novel structure‐based peptide‐HLA docking algorithm

T. Ashizawa, A. Iizuka, K. Yamaguchi, 2011, Cancer science.

Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay

T. Ashizawa, A. Iizuka, H. Miyata, 2012, Cancer Immunology, Immunotherapy.

Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.

T. Ashizawa, A. Iizuka, H. Miyata, 2013, International journal of oncology.

The identification of affinity peptide ligands specific to the variable region of human antibodies.

T. Ashizawa, H. Miyata, K. Yamaguchi, 2014, Biomedical research.

Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.

T. Ashizawa, A. Iizuka, K. Yamaguchi, 2011, Immunology letters.

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.

T. Ashizawa, A. Iizuka, H. Miyata, 2014, Oncology reports.

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.

Akira Iizuka, Masaru Komiyama, Koichi Mitsuya, 2014, Oncology reports.

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

T. Ashizawa, A. Iizuka, H. Miyata, 2012, BMC Cancer.

Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning.

T. Ashizawa, A. Iizuka, K. Yamaguchi, 2014, Immunology letters.

Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial

T. Ashizawa, A. Iizuka, H. Miyata, 2012, Oncology reports.

Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.

T. Ashizawa, H. Miyata, Y. Akiyama, 2011, International journal of oncology.

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.

T. Ashizawa, A. Iizuka, H. Miyata, 2014, Oncology reports.